The shares of German agricultural and energy conglomerate BayWa are caught in a tug-of-war between a long-awaited restructuring breakthrough and a growing pile of execution risks. While negotiations with lenders have entered their final phase, the stock slipped 7.5% to €11.05 on the latest trading day, bringing its year-to-date loss to more than 34%. Earlier in the week, a rally of about 9% had lifted the shares to €11.95 on optimism that a deal was close, but the price action since then reveals deep skepticism that a simple debt haircut can fix the group’s structural problems.
According to financial sources, the main creditor banks and the company’s owners are haggling over only technical details. An initial rescue blueprint from last year had to be rewritten after revised projections from the renewables division BayWa r.e. forced changes. The new concept reportedly calls for lenders to waive roughly €1 billion in debt. That write-off, combined with asset sales that have already raised about €1.3 billion, is meant to bring the group’s debt down by €4 billion by 2028. Yet a significant funding gap remains — a gap that only additional disposals can close.
The two most likely candidates for sale are the troubled renewables arm BayWa r.e. and New Zealand fruit producer T&G Global. An earlier attempt to spin off BayWa r.e. collapsed in the spring after US subsidy cuts erased the assumed purchase price of €1.7 billion, making the whole process far more difficult. At T&G, where BayWa holds a near-74% stake, a minority shareholder from Hong Kong is blocking the sale process. Without proceeds from at least one of these exits, the entire restructuring plan loses its financial backbone.
There is a sliver of positive operational news. In the first quarter of 2026, the group’s adjusted EBITDA — as well as its adjusted operating profit — exceeded the targets set out in the restructuring plan. Revenue fell from €3.6 billion to €2.3 billion, but management attributed the decline to deliberate disposals such as the Cefetra Group, not to a broader business collapse.
Should investors sell immediately? Or is it worth buying BayWa?
The legal thunderclouds, however, are growing darker. The Munich I public prosecutor’s office launched an investigation at the end of June into former CEOs Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and misrepresentation in the 2023 annual report. The regulator BaFin had already censured BayWa for omitting key details about a billion-euro loan in that same report. The fallout continues: auditor PwC lost its mandate, and KPMG has been brought in. Until a clean, audited 2025 annual report is delivered — now expected only in the fourth quarter of 2026 — investors are left with no reliable fundamental data on which to base decisions.
That audit delay ties directly into the three conditions that BayWa must meet before its autumn 2026 hard deadline. The standstill agreement with its lenders gives the board only a few more months of breathing room. By then, three interdependent boxes must be ticked: a signed-off 2025 annual report, a formal extension of the standstill, and the completed sale of T&G Global. All three are uncertain, and if one falls, the entire rescue construction wobbles.
With annualized volatility above 80%, BayWa’s shares remain a deeply speculative bet. The path to stability requires a delicate choreography of legal settlements, creditor negotiations, and asset disposals — and the music stops in October.
Ad
BayWa Stock: Buy or Sell?! New BayWa Analysis from June 29 delivers the answer:
The latest BayWa figures speak for themselves: Urgent action needed for BayWa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 29.
BayWa: Buy or sell? Read more here...
